Europe – New agreement places Northern Ireland regulation back in the UK

Regulation of human medicines in Northern Ireland now are the responsibility of the UK Medicines and Healthcare products Regulatory Agency (MRHA) under an changes...

Europe – EMA Procedural Advice on Recommendations on unforeseen variations according to Article 5...

Article 3 paragraph 1 of Commission Regulation (EC) No 1234/2008 (Variation Regulation) refers to Annex II where a classification of minor variations, type IA...

Europe – EMA pilots scientific advice for certain high-risk medical devices

EMA has launched a pilot to give scientific advice on the intended clinical development strategy and proposals for clinical investigation for certain high-risk medical devices (all...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – MHRA safety review of medicines containing pseudoephedrine

Pseudoephedrine is used for the symptomatic relief of coughs, colds and allergies. Pseudoephedrine has been used in the UK for decades in millions and...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – European Commission grants AstraZeneca three new approvals

The Imfinzi/ Imjudo approvals authorise the combination to be used for the first line treatment of adult patients with advanced or unresectable hepatocellular carcinoma...

UK – NICE publishes final draft guidance recommending three COVID-19 treatments

This includes those who are immunosuppressed, or who have other conditions such as heart disease, respiratory disease, diabetes or neurological disorders. The agency’s latest guidance...

NOS PROCHAINES FORMATIONS